SymBio, Singapore’s National Cancer Centre Tie Up to Investigate Brincidofovir’s Anti-Tumor Activity

SymBio Pharmaceuticals said on September 1 that it has entered into a collaborative research agreement with the National Cancer Centre Singapore (NCCS) to look into the anti-tumor activity and the mechanism of action for an intravenous formulation of the antiviral...read more